vs
MIDDLEBY Corp（MIDD）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是MIDDLEBY Corp的1.6倍（$1.4B vs $866.4M），瑞思迈净利率更高（27.6% vs 4.3%，领先23.3%），瑞思迈同比增速更快（11.0% vs -30.6%），瑞思迈自由现金流更多（$311.2M vs $165.5M），过去两年瑞思迈的营收复合增速更高（9.0% vs -3.3%）
美国Middleby公司是总部位于伊利诺伊州埃尔金的上市企业，主营商用烹饪设备、工业加工设备及民用家电，其商用烹饪设备业务覆盖美国及全球前100家餐饮连锁品牌中的97家，是全球餐饮设备领域的领先供应商。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
MIDD vs RMD — 直观对比
营收规模更大
RMD
是对方的1.6倍
$866.4M
营收增速更快
RMD
高出41.5%
-30.6%
净利率更高
RMD
高出23.3%
4.3%
自由现金流更多
RMD
多$145.7M
$165.5M
两年增速更快
RMD
近两年复合增速
-3.3%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $866.4M | $1.4B |
| 净利润 | $36.9M | $392.6M |
| 毛利率 | 38.8% | 61.8% |
| 营业利润率 | 17.3% | 34.6% |
| 净利率 | 4.3% | 27.6% |
| 营收同比 | -30.6% | 11.0% |
| 净利润同比 | -67.1% | 13.9% |
| 每股收益（稀释后） | $0.74 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MIDDRMD
| Q4 25 | $866.4M | $1.4B | ||
| Q3 25 | $982.1M | $1.3B | ||
| Q2 25 | $977.9M | $1.3B | ||
| Q1 25 | $906.6M | $1.3B | ||
| Q4 24 | $1.0B | $1.3B | ||
| Q3 24 | $942.8M | $1.2B | ||
| Q2 24 | $991.5M | $1.2B | ||
| Q1 24 | $926.9M | $1.2B |
净利润MIDDRMD
| Q4 25 | $36.9M | $392.6M | ||
| Q3 25 | $-513.0M | $348.5M | ||
| Q2 25 | $106.0M | $379.7M | ||
| Q1 25 | $92.4M | $365.0M | ||
| Q4 24 | $112.3M | $344.6M | ||
| Q3 24 | $114.2M | $311.4M | ||
| Q2 24 | $115.4M | $292.2M | ||
| Q1 24 | $86.6M | $300.5M |
毛利率MIDDRMD
| Q4 25 | 38.8% | 61.8% | ||
| Q3 25 | 36.8% | 61.5% | ||
| Q2 25 | 38.0% | 60.8% | ||
| Q1 25 | 38.2% | 59.3% | ||
| Q4 24 | 38.4% | 58.6% | ||
| Q3 24 | 37.7% | 58.6% | ||
| Q2 24 | 38.3% | 58.5% | ||
| Q1 24 | 37.4% | 57.9% |
营业利润率MIDDRMD
| Q4 25 | 17.3% | 34.6% | ||
| Q3 25 | -56.4% | 33.4% | ||
| Q2 25 | 15.9% | 33.7% | ||
| Q1 25 | 15.5% | 33.0% | ||
| Q4 24 | 16.8% | 32.5% | ||
| Q3 24 | 18.4% | 31.6% | ||
| Q2 24 | 17.7% | 31.2% | ||
| Q1 24 | 14.8% | 31.3% |
净利率MIDDRMD
| Q4 25 | 4.3% | 27.6% | ||
| Q3 25 | -52.2% | 26.1% | ||
| Q2 25 | 10.8% | 28.2% | ||
| Q1 25 | 10.2% | 28.3% | ||
| Q4 24 | 11.1% | 26.9% | ||
| Q3 24 | 12.1% | 25.4% | ||
| Q2 24 | 11.6% | 23.9% | ||
| Q1 24 | 9.3% | 25.1% |
每股收益（稀释后）MIDDRMD
| Q4 25 | $0.74 | $2.68 | ||
| Q3 25 | $-10.15 | $2.37 | ||
| Q2 25 | $1.99 | $2.58 | ||
| Q1 25 | $1.69 | $2.48 | ||
| Q4 24 | $2.07 | $2.34 | ||
| Q3 24 | $2.11 | $2.11 | ||
| Q2 24 | $2.13 | $1.97 | ||
| Q1 24 | $1.59 | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $222.2M | $1.4B |
| 总债务越低越好 | $2.2B | $403.9M |
| 股东权益账面价值 | $2.8B | $6.3B |
| 总资产 | $6.3B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.78× | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资MIDDRMD
| Q4 25 | $222.2M | $1.4B | ||
| Q3 25 | $175.1M | $1.4B | ||
| Q2 25 | $511.5M | $1.2B | ||
| Q1 25 | $745.1M | $932.7M | ||
| Q4 24 | $689.5M | $521.9M | ||
| Q3 24 | $606.0M | $426.4M | ||
| Q2 24 | $459.5M | $238.4M | ||
| Q1 24 | $341.0M | $237.9M |
总债务MIDDRMD
| Q4 25 | $2.2B | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | $2.4B | $662.9M | ||
| Q3 24 | — | $667.6M | ||
| Q2 24 | — | $697.3M | ||
| Q1 24 | — | $997.0M |
股东权益MIDDRMD
| Q4 25 | $2.8B | $6.3B | ||
| Q3 25 | $2.9B | $6.1B | ||
| Q2 25 | $3.6B | $6.0B | ||
| Q1 25 | $3.7B | $5.5B | ||
| Q4 24 | $3.6B | $5.3B | ||
| Q3 24 | $3.6B | $5.2B | ||
| Q2 24 | $3.4B | $4.9B | ||
| Q1 24 | $3.3B | $4.6B |
总资产MIDDRMD
| Q4 25 | $6.3B | $8.5B | ||
| Q3 25 | $6.4B | $8.3B | ||
| Q2 25 | $7.3B | $8.2B | ||
| Q1 25 | $7.4B | $7.6B | ||
| Q4 24 | $7.3B | $7.1B | ||
| Q3 24 | $7.2B | $7.2B | ||
| Q2 24 | $7.0B | $6.9B | ||
| Q1 24 | $6.9B | $6.8B |
负债/权益比MIDDRMD
| Q4 25 | 0.78× | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | 0.66× | 0.13× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $165.5M | $311.2M |
| 自由现金流率自由现金流/营收 | 19.1% | 21.9% |
| 资本支出强度资本支出/营收 | 1.5% | 2.0% |
| 现金转化率经营现金流/净利润 | — | 0.87× |
| 过去12个月自由现金流最近4个季度 | $530.1M | $1.8B |
8季度趋势，按日历期对齐
经营现金流MIDDRMD
| Q4 25 | — | $339.7M | ||
| Q3 25 | $176.3M | $457.3M | ||
| Q2 25 | $122.0M | $538.8M | ||
| Q1 25 | $141.1M | $578.7M | ||
| Q4 24 | $239.7M | $308.6M | ||
| Q3 24 | $156.7M | $325.5M | ||
| Q2 24 | $149.5M | $440.1M | ||
| Q1 24 | $140.9M | $402.0M |
自由现金流MIDDRMD
| Q4 25 | $165.5M | $311.2M | ||
| Q3 25 | $156.1M | $414.4M | ||
| Q2 25 | $101.1M | $508.2M | ||
| Q1 25 | $107.4M | $557.9M | ||
| Q4 24 | $226.6M | $288.0M | ||
| Q3 24 | $145.2M | $307.7M | ||
| Q2 24 | $138.6M | $415.2M | ||
| Q1 24 | $127.2M | $380.8M |
自由现金流率MIDDRMD
| Q4 25 | 19.1% | 21.9% | ||
| Q3 25 | 15.9% | 31.0% | ||
| Q2 25 | 10.3% | 37.7% | ||
| Q1 25 | 11.8% | 43.2% | ||
| Q4 24 | 22.3% | 22.5% | ||
| Q3 24 | 15.4% | 25.1% | ||
| Q2 24 | 14.0% | 33.9% | ||
| Q1 24 | 13.7% | 31.8% |
资本支出强度MIDDRMD
| Q4 25 | 1.5% | 2.0% | ||
| Q3 25 | 2.1% | 3.2% | ||
| Q2 25 | 2.1% | 2.3% | ||
| Q1 25 | 3.7% | 1.6% | ||
| Q4 24 | 1.3% | 1.6% | ||
| Q3 24 | 1.2% | 1.5% | ||
| Q2 24 | 1.1% | 2.0% | ||
| Q1 24 | 1.5% | 1.8% |
现金转化率MIDDRMD
| Q4 25 | — | 0.87× | ||
| Q3 25 | — | 1.31× | ||
| Q2 25 | 1.15× | 1.42× | ||
| Q1 25 | 1.53× | 1.59× | ||
| Q4 24 | 2.13× | 0.90× | ||
| Q3 24 | 1.37× | 1.05× | ||
| Q2 24 | 1.30× | 1.51× | ||
| Q1 24 | 1.63× | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MIDD
暂无分部数据
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
